| Name | [Arg14,Lys15]Nociceptin |
|---|---|
| Synonyms | phe-gly-gly-phe-thr-gly-ala-arg-lys-ser-ala-arg-lys-arg-lys-asn-gln |
| Description | [Arg14,Lys15]Nociceptin is a highly potent and selective NOP receptor agonist, with an EC50 of 1 nM. [Arg14,Lys15]Nociceptin displays high selectivity over opioid receptors, with IC50s of 0.32, 280, >10000 and 1500 nM for NOP (ORL1; OP4), μ, δ and κ receptors, respectively[1]. |
|---|---|
| Related Catalog | |
| In Vitro | [Arg14,Lys15]Nociceptin is about 30-fold more potent than Nociceptin (NC) and produces longer lasting effects[2]. |
| In Vivo | In in vivo experiments, [Arg14,Lys15]Nociceptin mimics the effects of NC, producing, after intracerebroventricular administration, pronociceptive effects in the tail-withdrawal assay and inhibiting the locomotor activity of the mice[2]. |
| References |
| Molecular Formula | C82H137N31O22 |
|---|---|
| Molecular Weight | 1909.16000 |
| Exact Mass | 1908.06000 |
| PSA | 919.32000 |
| LogP | 1.29430 |
| Safety Phrases | 22-24/25 |
|---|---|
| WGK Germany | 3 |